TABLE 3.
Enrollment Eligibility Groups
|
|||
---|---|---|---|
Eligible | Ineligible | Indeterminate | |
Period between enrollment and reaching ART eligibility | |||
LTF: 6 mo | N/A | 7.2% (6.8 to 7.7) | 11.7% (10.9 to 12.4) |
LTF: 12 mo | N/A | 10.1% (9.5 to 10.6) | 13.8% (13.0 to 14.6) |
Mortality: 6 mo | N/A | 0.6% (0.5 to 0.8) | 2.2% (1.9 to 2.6) |
Mortality: 12 mo | N/A | 1.2% (1.0 to 1.4) | 3.2% (2.8 to 3.6) |
Reached ART eligibility: 6 mo | N/A | 8.0% (7.6 to 8.5) | 12.9% (12.1 to 13.7) |
Reached ART eligibility: 12 mo | N/A | 17.9% (17.2 to 18.6) | 22.8% (21.7 to 23.8) |
Period between ART eligibility and ART initiation | |||
LTF: 6 mo | 2.7% (2.4 to 3.1) | 1.5% (1.2 to 1.9) | 1.5% (1.1 to 2.1) |
LTF: 12 mo | 3.1% (2.7 to 3.4) | 2.1% (1.7 to 2.6) | 2.2% (1.6 to 2.8) |
Mortality: 6 mo | 2.8% (2.5 to 3.2) | 0.6% (0.4 to 1.0) | 1.3% (0.9 to 1.8) |
Mortality: 12 mo | 3.3% (2.9 to 3.6) | 0.7% (0.5 to 1.0) | 1.5% (1.0 to 2.1) |
Initiated ART: 1 mo (30 days) | 53.0% (52.0 to 54.0) | 41.5% (40.0 to 43.0) | 40.8% (38.8 to 42.7) |
Initiated ART: 3 months (90 days) | 77.2% (76.4 to 78.0) | 67.9% (66.4 to 69.3) | 63.8% (61.9 to 65.8) |
Initiated ART: 6 months (180 days) | 83.2% (82.4 to 83.9) | 77.2% (75.8 to 78.5) | 74.0% (72.0 to 75.7) |
Initiated ART: 12 months (365 days) | 87.6% (86.9 to 88.2) | 85.5% (84.3 to 86.5) | 83.7% (82.0 to 85.1) |
All values are represented as cumulative incidence (95% CI).